The landscape of blood sugar treatment is evolving with the introduction of transdermal GLP-1 delivery . These innovative devices offer a possibly more comfortable alternative to injections for individuals managing diabetes 2. They deliver a GLP-1 agonist directly through the epidermis, circumven